Standardized packaging solution for a fast time-to-market
Download the whitepaper to explore how standardized packaging solutions cut costs and mitigate contamination risks!
The rise of biologics in the pharmaceutical pipeline, the more rapid market entry of biosimilars, and the pressure to bring new products to market faster — at lower costs — impact fill-and-finish operations. As new drugs are commercialized, manufacturing is scaled up and scaled out, with production occurring parallel across several facilities to supply local markets. This strategy is an important way to derisk the supply chain by reducing reliance on a single, centrally located production line. Key to this strategy, however, is a standardized machine concept that can operate with ready-to-use (RTU) packaging components.
Read the whitepaper to explore how the SCHOTT iQ® platform can increase operational flexibility and reduce the total cost of ownership of fill-and-finish operations!
The article was initially published in Manufacturing Chemist in January 2023.
The rise of biologics in the pharmaceutical pipeline, the more rapid market entry of biosimilars, and the pressure to bring new products to market faster — at lower costs — impact fill-and-finish operations. As new drugs are commercialized, manufacturing is scaled up and scaled out, with production occurring parallel across several facilities to supply local markets. This strategy is an important way to derisk the supply chain by reducing reliance on a single, centrally located production line. Key to this strategy, however, is a standardized machine concept that can operate with ready-to-use (RTU) packaging components.
Read the whitepaper to explore how the SCHOTT iQ® platform can increase operational flexibility and reduce the total cost of ownership of fill-and-finish operations!
The article was initially published in Manufacturing Chemist in January 2023.
